107 related articles for article (PubMed ID: 8448895)
1. Elevated levels of the p53 tumour suppressor protein in the basal layer of recurrent laryngeal papillomas.
Clark LJ; MacKenzie K; Parkinson EK
Clin Otolaryngol Allied Sci; 1993 Feb; 18(1):63-5. PubMed ID: 8448895
[TBL] [Abstract][Full Text] [Related]
2. New aspects in the pathology of the preneoplastic lesions of the larynx.
Sugár J; Vereczkey I; Tóth J; Péter I; Bánhidy F
Acta Otolaryngol Suppl; 1997; 527():52-6. PubMed ID: 9197482
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and expression of p53 and c-erbB-2 protein in laryngeal papillomas.
Luzar B; Gale N; Kambic V; Poljak M; Zidar N; Vodovnik A
Acta Otolaryngol Suppl; 1997; 527():120-4. PubMed ID: 9197499
[TBL] [Abstract][Full Text] [Related]
4. Expression of the the cyclin-kinase inhibitors p21(WAF1) and p27(Kip1) and the p53 tumor suppressor genes in adult-onset laryngeal papillomas.
Erdamar B; Keles N; Kaur A; Suoglu Y; Kiyak E
Eur Arch Otorhinolaryngol; 2002 Nov; 259(10):516-20. PubMed ID: 12434183
[TBL] [Abstract][Full Text] [Related]
5. p53 protein overexpression in laryngeal squamous cell papillomas.
Poljak M; Gale N; Kambic V; Luzar B
Anticancer Res; 1997; 17(3C):2201-5. PubMed ID: 9216688
[TBL] [Abstract][Full Text] [Related]
6. Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas.
Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H
J Clin Pathol; 2001 Nov; 54(11):871-6. PubMed ID: 11684723
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis.
Pham TT; Ongkeko WM; An Y; Yi ES
Laryngoscope; 2007 Feb; 117(2):253-7. PubMed ID: 17277618
[TBL] [Abstract][Full Text] [Related]
8. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
[TBL] [Abstract][Full Text] [Related]
9. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
Gorban' NA; Ten VP; Pankratov VA
Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
[TBL] [Abstract][Full Text] [Related]
10. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
Go C; Schwartz MR; Donovan DT
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
[TBL] [Abstract][Full Text] [Related]
11. Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis.
Kropveld A; Slootweg PJ; van Mansfeld AD; Blankenstein MA; Hordijk GJ
Cancer; 1996 Sep; 78(5):991-7. PubMed ID: 8780536
[TBL] [Abstract][Full Text] [Related]
12. Differences in C/EBPs in normal tissue and papillomas of the larynx.
Jin L; Yang GY; Auborn K
Cell Prolif; 1998; 31(3-4):127-38. PubMed ID: 9853426
[TBL] [Abstract][Full Text] [Related]
13. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors.
Nadal A; Campo E; Pinto J; Mallofré C; Palacín A; Arias C; Traserra J; Cardesa A
J Pathol; 1995 Feb; 175(2):181-8. PubMed ID: 7738713
[TBL] [Abstract][Full Text] [Related]
14. [Protein P53 in laryngeal cancer--no evidence of prognostic value].
Woińska-Rojecka T; Chodynicki S; Chyczewski L; Pogumirski J
Otolaryngol Pol; 2001; 55(1):53-6. PubMed ID: 11355478
[TBL] [Abstract][Full Text] [Related]
15. p53 over-expression in laryngeal carcinoma is not predictive of response to radiotherapy.
Tan LK; Ogden GR
Oral Oncol; 1997 May; 33(3):177-81. PubMed ID: 9307726
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998.
Buchwald C; Lindeberg H; Pedersen BL; Franzmann MB
Laryngoscope; 2001 Jun; 111(6):1104-10. PubMed ID: 11404629
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck.
Lavieille JP; Brambilla E; Riva-Lavieille C; Reyt E; Charachon R; Brambilla C
Acta Otolaryngol; 1995 Mar; 115(2):334-9. PubMed ID: 7610836
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of p53, p21 and Cdc2 in histologically negative surgical margins is correlated with local recurrence of laryngeal squamous cell carcinoma.
Yang JQ; Liu HX; Liang Z; Sun YM; Wu M
Int J Clin Exp Pathol; 2014; 7(7):4295-302. PubMed ID: 25120812
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
Gale N; Zidar N; Kambic V; Poljak M; Cör A
Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
